Harvard Bioscience (HBIO) Non Operating Investment Income (2023 - 2024)
Harvard Bioscience (HBIO) posted quarterly Non Operating Investment Income of -$281000.0 for Q2 2024, up 82.23% year-over-year from -$154203.7 in Q3 2023, and up 78.58% quarter-over-quarter from -$1.3 million in Q1 2024.
Harvard Bioscience (HBIO) Non Operating Investment Income (2023 - 2024) Analysis & Trends
Harvard Bioscience (HBIO) has reported Non Operating Investment Income for 2 consecutive years, with -$281000.0 the latest figure, recorded in Q2 2024.
- In Q2 2024, Non Operating Investment Income rose 82.23% year-over-year to -$281000.0; the TTM figure through Mar 2025 stood at -$281000.0 (up 85.55% YoY), while the FY2024 annual figure was -$1.6 million, down 152.06% from the prior year.
- Non Operating Investment Income rose to -$281000.0 in Q2 2024 per HBIO's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $1.2 million in Q3 2023 and bottomed at -$1.6 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.00 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -281,000.00 |
| Jun 30, 2024 | -281,000.00 |
| Mar 31, 2024 | -1.31 Mn |
| Mar 31, 2024 | -1.31 Mn |
| Dec 31, 2023 | -259,000.00 |
| Dec 31, 2023 | -259,000.00 |
| Sep 30, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Jun 30, 2023 | -1.58 Mn |